Skip to content

Clinical trials

Phase 1/2 Retinitis Pigmentosa trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Phase: Phase 1/2 Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20111
20122
20144
20153
20171
20183
20196
20202
20223
20231
20243
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting9
Active, not recruiting8
Terminated4
Unknown status4
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sheba Medical Center3
ProQR Therapeutics2
SparingVision2
AAVantgarde Bio Srl1
AbbVie1
Ace Cells Lab Limited1
Acibadem University1
Allergan1
Bionic Sight LLC1
BlueRock Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa41
Eye Diseases8
Retinal Degeneration7
Retinal Diseases6
Cone-Rod Dystrophies5
Eye Diseases, Hereditary4
Retinal Dystrophies4
Usher Syndromes4
Vision Disorders3
Choroideremia2

Trials

Showing 26 to 41 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.